OKUR OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc. (OKUR) Hedge Fund Activity
This view isolates hedge funds from the broader institutional ownership shown on the Institutional tab. A pension fund tracking an index may have no view on a stock; when a hedge fund builds or exits a position, that decision can carry information. This page measures those changes. Positions as of June 30, 2026.
Based on quarterly 13F long-equity filings. Changes compare reported quarter-end positions; filings can be reported up to 45 days later and do not represent a fund's complete exposure.
Most significant moves
Ranked by conviction, not size — how much of the fund's own book the position represents, how far it moved, and what kind of fund made it.
| Fund | Action | Shares changed | Change | Est. value | Portfolio wt. | Score |
|---|---|---|---|---|---|---|
| Logos Global Management Growth Healthcare | New | +963.9K | — | $4.4M | 0.2% | 58 |
| MILLENNIUM MANAGEMENT LLC | Sold Out | -30.5K | -100.0% | $139.1K | 0.0% | 57 |
| CITADEL ADVISORS LLC Quant | Increased | +1.15M | +3058.1% | $5.2M | 0.0% | 54 |
| Walleye Capital Long/Short Quant | New | +71.1K | — | $324.2K | 0.0% | 51 |
| TWO SIGMA INVESTMENTS, LP Quant | Increased | +84.6K | +348.7% | $385.8K | 0.0% | 51 |
| MARSHALL WACE, LLP Long/Short | Increased | +123.4K | +338.7% | $562.9K | 0.0% | 50 |
| Y-Intercept Quant | New | +11.3K | — | $51.5K | 0.0% | 48 |
| Biotechnology Value Fund Value Healthcare | Increased | +1.26M | +63.5% | $5.7M | 0.4% | 47 |
| Vestal Point Capital Growth Healthcare | Reduced | -14.1K | -0.8% | $64.4K | 0.2% | 29 |
| RENAISSANCE TECHNOLOGIES LLC Quant | Reduced | -18.5K | -4.9% | $84.4K | 0.0% | 29 |
Most significant buyers
By move score, not size.
- Logos Global Management
- CITADEL ADVISORS LLC
- Walleye Capital
- TWO SIGMA INVESTMENTS, LP
- MARSHALL WACE, LLP
Most significant sellers
By move score, not size.
- MILLENNIUM MANAGEMENT LLC
- Vestal Point Capital
- RENAISSANCE TECHNOLOGIES LLC
- ADAR1 Capital Management
Hedge fund positions
| Fund | Tier | Shares | Previous | Change | Change % | Portfolio wt. | Action | Score |
|---|---|---|---|---|---|---|---|---|
| Logos Global Management | 2 | 963.9K | 0 | +963.9K | — | 0.2% | New | 58 |
| MILLENNIUM MANAGEMENT LLC | 2 | 0 | 30.5K | -30.5K | -100.0% | 0.0% | Sold Out | 57 |
| CITADEL ADVISORS LLC | 1 | 1.2M | 37.6K | +1.15M | +3058.1% | 0.0% | Increased | 54 |
| Walleye Capital | 3 | 71.1K | 0 | +71.1K | — | 0.0% | New | 51 |
| TWO SIGMA INVESTMENTS, LP | 2 | 108.9K | 24.3K | +84.6K | +348.7% | 0.0% | Increased | 51 |
| MARSHALL WACE, LLP | 2 | 159.9K | 36.4K | +123.4K | +338.7% | 0.0% | Increased | 50 |
| Y-Intercept | 4 | 11.3K | 0 | +11.3K | — | 0.0% | New | 48 |
| Biotechnology Value Fund | 1 | 3.2M | 2.0M | +1.26M | +63.5% | 0.4% | Increased | 47 |
| Vestal Point Capital | 1 | 1.8M | 1.8M | -14.1K | -0.8% | 0.2% | Reduced | 29 |
| RENAISSANCE TECHNOLOGIES LLC | 1 | 358.7K | 377.3K | -18.5K | -4.9% | 0.0% | Reduced | 29 |
| ADAR1 Capital Management | 3 | 2.2M | 2.4M | -196.3K | -8.1% | 0.5% | Reduced | 27 |
| RA Capital Management | 1 | 4.0M | 4.0M | 0 | +0.0% | 0.2% | Unchanged | 26 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2 | 1.2M | 1.2M | 0 | +0.0% | 0.0% | Unchanged | 20 |
| Affinity Asset Advisors | 2 | 241.0K | 241.0K | 0 | +0.0% | 0.1% | Unchanged | 19 |
Every fund above opens. Subscribers can see any manager's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeHedge funds are identified from their 13F filings, which are due 45 days after quarter end and cover long U.S.-listed equity positions only. A fund's short book never appears, so a reduced position can mean a changed view or a changed hedge — the filing doesn't say which.